CURE CMD
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2008-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.curecmd.org
Clinical Trials
4
Active:0
Completed:2
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
LAMA2-related Muscular Dystrophy Brain Study
Withdrawn
- Conditions
- LAMA2-MD (Merosin Deficient Congenital Muscular Dystrophy, MDC1A)
- First Posted Date
- 2013-09-27
- Last Posted Date
- 2018-03-07
- Lead Sponsor
- Cure CMD
- Registration Number
- NCT01952028
- Locations
- 🇺🇸
CMDIR, San Pedro, California, United States
Myotubular Myopathy Event Study
Completed
- Conditions
- X-linked Myotubular Myopathy
- First Posted Date
- 2013-04-26
- Last Posted Date
- 2018-03-07
- Lead Sponsor
- Cure CMD
- Target Recruit Count
- 33
- Registration Number
- NCT01840657
- Locations
- 🇺🇸
CMDIR, Torrance, California, United States
Myotubular Myopathy Genetic Testing Study
Completed
- Conditions
- Myotubular Myopathy
- First Posted Date
- 2013-03-26
- Last Posted Date
- 2018-03-07
- Lead Sponsor
- Cure CMD
- Target Recruit Count
- 23
- Registration Number
- NCT01817946
- Locations
- 🇺🇸
Congenital Muscle Disease International Registry, Torrance, California, United States
Congenital Muscle Disease Study of Patient and Family Reported Medical Information
Recruiting
- Conditions
- Alpha-Dystroglycanopathy (Dystroglycanopathy, Congenital With or Without Mental Retardation (Formerly MDC1C))Alpha-Dystroglycanopathy (LGMDR09 FKRP Related (Formerly LGMD2I))Alpha-Dystroglycanopathy (LGMDR13 FKTN Related (Formerly LGMD2M))Alpha-Dystroglycanopathy (LGMDR14 POMT2 Related (Formerly LGMD2N))Alpha-Dystroglycanopathy (LGMDR15 POMGnT1 Related (Formerly LGMD2O))Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy With Hypoglycosylation of Dystroglycan and Epilepsy)Alpha-Dystroglycanopathy (Fukuyama CMD)Alpha-Dystroglycanopathy (LGMDR11 POMT1 Related (Formerly LGMD2K))Collagen XII Related DisordersGOLGA2-related Congenital Muscle Dystrophy With Brain Involvement
- First Posted Date
- 2011-07-27
- Last Posted Date
- 2021-08-09
- Lead Sponsor
- Cure CMD
- Target Recruit Count
- 4000
- Registration Number
- NCT01403402
- Locations
- 🇺🇸
Congenital Muscle Disease International Registry (www.cmdir.org), Lakewood, California, United States
News
No news found